From EHR-based patient recruitment to decentralized clinical trials, we break down the critical categories of vendors digitizing clinical trials.
Developing a new drug is a time-consuming and costly process. Getting a drug to market can take 10+ years and cost billions of dollars. In addition, Covid-19 forced pharma players to rethink how clinical trials are conducted, with the pandemic forcing many trials to be put on hold.
Tech vendors are helping pharma companies and other healthcare organizations address roadblocks throughout the clinical trial process. For instance, EHR-based patient recruitment solutions help improve adherence to enrollment deadlines, while decentralized clinical trials can increase patient accessibility and diversity.
In the market map below, we identify 63 vendors digitizing clinical trials across 10 different categories.
Note: Our map includes public companies or private startups that have either submitted an Analyst Briefing or have at least $20M of funding, have a Mosaic score of at least 400, and have received funding in the last 5 years. This market map is not exhaustive of the space.
Please click to enlarge.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
